16,200 Shares in LifeVantage Co. (NASDAQ:LFVN) Acquired by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp bought a new position in shares of LifeVantage Co. (NASDAQ:LFVN) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 16,200 shares of the company’s stock, valued at approximately $284,000.

A number of other large investors have also bought and sold shares of LFVN. Ritholtz Wealth Management increased its stake in LifeVantage by 65.2% during the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock worth $830,000 after purchasing an additional 18,682 shares in the last quarter. Copeland Capital Management LLC bought a new position in shares of LifeVantage during the 4th quarter worth approximately $65,000. Bank of New York Mellon Corp grew its stake in shares of LifeVantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock worth $1,300,000 after acquiring an additional 22,620 shares in the last quarter. American Century Companies Inc. grew its stake in shares of LifeVantage by 50.5% during the 4th quarter. American Century Companies Inc. now owns 95,552 shares of the company’s stock worth $1,675,000 after acquiring an additional 32,055 shares in the last quarter. Finally, Hillsdale Investment Management Inc. grew its stake in shares of LifeVantage by 7.3% during the 4th quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company’s stock worth $258,000 after acquiring an additional 1,000 shares in the last quarter. 35.32% of the stock is owned by institutional investors.

LifeVantage Stock Down 1.6%

Shares of LFVN opened at $13.18 on Tuesday. The stock has a market capitalization of $165.91 million, a P/E ratio of 23.54 and a beta of 0.41. LifeVantage Co. has a twelve month low of $5.22 and a twelve month high of $27.38. The company has a 50 day moving average of $13.85 and a 200-day moving average of $16.33.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.16 by $0.10. The company had revenue of $58.44 million during the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 1.37%. The ex-dividend date of this dividend is Friday, May 30th. This is an increase from LifeVantage’s previous quarterly dividend of $0.04. LifeVantage’s dividend payout ratio is presently 26.09%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.